Effect of suppressive acyclovir administered to HSV-2 positive mothers from week 28 to 36 weeks of pregnancy on adverse obstetric outcomes: a double-blind randomised placebo-controlled trial
Crossref DOI link: https://doi.org/10.1186/s12978-017-0292-7
Published Online: 2017-03-03
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nakubulwa, Sarah
Kaye, Dan K.
Bwanga, Freddie
Tumwesigye, Nazarius Mbona
Nakku-Joloba, Edith
Mirembe, Florence
Funding for this research was provided by:
MEPI/MESAU (5R24TW008886)
Consortium for Advanced Research Training in Africa (CARTA) (087547/Z/08/Z)